The Oxford Biobank aims to be largest exome-chipped control cohort in the UK in order to support the development of personalised medicine. Here is a brief summary of the Biobank’s activities:
- 6,500 (Nov 2013) men and women recruited within the age range of 30 to 50 years.
- All participants undergo detailed examination at a screening visit (questionnaires, biochemistry, anthropometrics).
- Participant characterisation includes; anthropometric characterisation (including DXA scans), beyond conventional diabetes / obesity and cardiovascular conventional biochemistry, hCRP, IGF-1, IGFBP1 and fasting insulin concentrations.
- At recruitments, participants donate DNA and give informed consent to be re-approached.
- Re-approach studies can be based on genetic or phenotypic criteria providing an excellent tool for functional genomics and translational medicine research.
- Users of data from the Oxford Biobank will always work on completely anonymised data.
To find out more about the work of the Oxford Biobank click here.
To watch a podcast about Prof Karpe’s research into obesity and diabetes click here.
The Oxford Biobank can be used by internal (University of Oxford and Oxford University Hospitals NHS Trust) and external investigators. The Oxford Biobank steering committee will prioritise proposals. Once the proposals are accepted, a costing model will be calculated based on level of access and the nature of the work.
For key publications click here.
Have you been asked to volunteer and want to know more about other volunteers’ experiences? Click here.
For contact details click here: